MedPath

Hybrid Resin Composite Vs. Hybrid Ceramic Onlays for Restoring Carious Molars

Not Applicable
Not yet recruiting
Conditions
Carious Molars
Registration Number
NCT06820840
Lead Sponsor
Peter Medhat Youssef Gerges
Brief Summary

The goal of this clinical trial is to compare the clinical performance of hybrid resin composite and hybrid ceramic onlays in restoring carious molars. It will also evaluate the wear resistance of both materials. The main questions it aims to answer are:

* Does the hybrid resin composite or hybrid ceramic onlay perform better in clinical settings over time?

* How much wear occurs in each type of onlay over 18 months?

Researchers will compare SHOFU Ceramage (hybrid resin composite) to SHOFU HC (hybrid ceramic) to see which material performs better in restoring molars with extensive caries.

Participants will:

* Receive either a hybrid resin composite or hybrid ceramic onlay for their molar cavities.

* Visit the clinic for checkups at baseline, 6 months, 12 months, and 18 months.

* Undergo visual assessments of their restorations and quantitative wear analysis during follow-ups.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Able to tolerate necessary restorative procedures
  • Willing to sign the informed consent
  • Accepts the follow-up period
Exclusion Criteria
  • ICDAS 4/5 cavities in first and second permanent molars
  • Onlay cavities with at least one cusp coverage
  • Patients with acceptable oral hygiene

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Clinical PerformanceFrom baseline to 18 months

Measured using modified USPHS criteria

Secondary Outcome Measures
NameTimeMethod
Quantitative Wear AnalysisFrom baseline to 18 months

Measured in micrometers (μm) using a three-dimensional surface-based superimposition software

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.